Clinical trial end points for high-grade glioma: the evolving landscape.

导出 LinkOut

翻译打印收藏纠错

作者： David A,Reardon ^[1] ; Evanthia,Galanis ; John F,DeGroot ; Timothy F,Cloughesy ; Jeffrey S,Wefel ; Kathleen R,Lamborn ; Andrew B,Lassman ; Mark R,Gilbert ; John H,Sampson ; Wolfgang,Wick ; Marc C,Chamberlain ; David R,Macdonald ; Minesh P,Mehta ; Michael A,Vogelbaum ; Susan M,Chang ; Martin J,Van den Bent ; Patrick Y,Wen

作者单位： The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, Durham, NC 27710, USA. reard003@mc.duke.edu ^[1]

主题词脑肿瘤(Brain Neoplasms);临床试验(主题)(Clinical Trials as Topic);神经胶质瘤(Glioma);人类(Humans);挽救疗法(Salvage Therapy);存活率(Survival Rate)

DOI 10.1093/neuonc/noq203

PMID 21310734

发布时间 2024-03-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交